Context: Although radiation exposure is an important predictor of thyroid cancer on diagnosis of a thyroid nodule, the relationship between childhood radiation exposure and thyroid nodules has not been comprehensively evaluated. Objective: To examine the association between internal I-131 thyroid dose and thyroid nodules in young adults exposed during childhood. Design, setting, and participants: In this cross-sectional study, we screened residents of Belarus aged ≤18 years at the time of the Chernobyl nuclear accident for thyroid disease (median age, 21 years) with thyroid palpation, ultrasonography, blood/urine analysis, and medical follow-up when appropriate. Eligible participants (N = 11,421) had intact thyroid glands and doses based on direct individual thyroid activity measurements. Main outcome measures: Excess odds ratios per Gray (EOR/Gy, scaled at age 5 years at exposure) for any thyroid nodule and for nodules grouped by cytology/histology, diameter size, and singularity. Results: Risk of any thyroid nodule increased significantly with I-131 dose and, for a given dose, with younger age at exposure. The EOR/Gy (95% confidence intervals) for neoplastic nodules (3.82; 0.87 to 15.52) was significantly higher than for nonneoplastic nodules (0.32; <0.03 to 0.70) and did not vary by size; whereas the EOR/Gy for nonneoplastic nodules did vary by size (P = 0.02) and was 1.55 (0.36 to 5.46) for nodules ≥10 mm and 0.02 (<-0.02 to 0.70) for nodules <10 mm. EORs/Gy for single and multiple nodules were comparable. Conclusions: Childhood exposure to internal I-131 is associated with increased risk of neoplastic thyroid nodules of any size and nonneoplastic nodules ≥10 mm.
Context: Although radiation exposure is an important predictor of thyroid cancer on diagnosis of a thyroid nodule, the relationship between childhood radiation exposure and thyroid nodules has not been comprehensively evaluated. Objective: To examine the association between internal I-131 thyroid dose and thyroid nodules in young adults exposed during childhood. Design, setting, and participants: In this cross-sectional study, we screened residents of Belarus aged ≤18 years at the time of the Chernobyl nuclear accident for thyroid disease (median age, 21 years) with thyroid palpation, ultrasonography, blood/urine analysis, and medical follow-up when appropriate. Eligible participants (N = 11,421) had intact thyroid glands and doses based on direct individual thyroid activity measurements. Main outcome measures: Excess odds ratios per Gray (EOR/Gy, scaled at age 5 years at exposure) for any thyroid nodule and for nodules grouped by cytology/histology, diameter size, and singularity. Results: Risk of any thyroid nodule increased significantly with I-131 dose and, for a given dose, with younger age at exposure. The EOR/Gy (95% confidence intervals) for neoplastic nodules (3.82; 0.87 to 15.52) was significantly higher than for nonneoplastic nodules (0.32; <0.03 to 0.70) and did not vary by size; whereas the EOR/Gy for nonneoplastic nodules did vary by size (P = 0.02) and was 1.55 (0.36 to 5.46) for nodules ≥10 mm and 0.02 (<-0.02 to 0.70) for nodules <10 mm. EORs/Gy for single and multiple nodules were comparable. Conclusions: Childhood exposure to internal I-131 is associated with increased risk of neoplastic thyroid nodules of any size and nonneoplastic nodules ≥10 mm.
Authors: G Mushkacheva; E Rabinovich; V Privalov; S Povolotskaya; V Shorokhova; S Sokolova; V Turdakova; E Ryzhova; P Hall; A B Schneider; D L Preston; E Ron Journal: Radiat Res Date: 2006-11 Impact factor: 2.841
Authors: M J Favus; A B Schneider; M E Stachura; J E Arnold; U Y Ryo; S M Pinsky; M Colman; M J Arnold; L A Frohman Journal: N Engl J Med Date: 1976-05-06 Impact factor: 91.245
Authors: Vladimir Drozdovitch; Olga Zhukova; Maria Germenchuk; Arkady Khrutchinsky; Tatiana Kukhta; Nickolas Luckyanov; Victor Minenko; Marina Podgaiskaya; Mikhail Savkin; Sergey Vakulovsky; Paul Voillequé; André Bouville Journal: J Environ Radioact Date: 2012-10-24 Impact factor: 2.674
Authors: Lydia B Zablotska; Eldar A Nadyrov; Olga N Polyanskaya; Robert J McConnell; Patrick O'Kane; Jay Lubin; Maureen Hatch; Mark P Little; Alina V Brenner; Ilya V Veyalkin; Vasilina V Yauseyenka; Andre Bouville; Vladimir V Drozdovitch; Viktor F Minenko; Yuri E Demidchik; Kiyohiko Mabuchi; Alexander V Rozhko Journal: Am J Epidemiol Date: 2015-10-05 Impact factor: 4.897
Authors: L B Zablotska; E Ron; A V Rozhko; M Hatch; O N Polyanskaya; A V Brenner; J Lubin; G N Romanov; R J McConnell; P O'Kane; V V Evseenko; V V Drozdovitch; N Luckyanov; V F Minenko; A Bouville; V B Masyakin Journal: Br J Cancer Date: 2010-11-23 Impact factor: 7.640
Authors: Krzysztof Kaliszewski; Dorota Diakowska; Beata Wojtczak; Marta Strutyńska-Karpińska; Paweł Domosławski; Krzysztof Sutkowski; Mateusz Głód; Waldemar Balcerzak; Zdzisław Forkasiewicz; Tadeusz Łukieńczuk Journal: PLoS One Date: 2016-01-19 Impact factor: 3.240
Authors: Carlos S Duque; Alejandro Vélez; Jorge Cuartas; Fabian Jaimes; Juan Pablo Dueñas; Miguel Agudelo; Marina N Nikiforova; Yuri E Nikiforov; Vincenzo Condello Journal: Endocrine Date: 2022-01-30 Impact factor: 3.925
Authors: C Ory; S Leboulleux; D Salvatore; B Le Guen; F De Vathaire; S Chevillard; M Schlumberger Journal: Endocrine Date: 2020-10-06 Impact factor: 3.633
Authors: Catherine C Lerro; Rena R Jones; Hilde Langseth; Tom K Grimsrud; Lawrence S Engel; Andreas Sjödin; Hyoyoung Choo-Wosoba; Paul Albert; Mary H Ward Journal: Environ Res Date: 2018-04-23 Impact factor: 6.498